Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic.

Abstract

Shigella is a major cause of morbidity, mortality, and growth retardation for children in developing countries. Emergence of antibiotic resistance among Shigellae demands the development of effective medicines. Previous studies found that the endogenous antimicrobial peptide LL-37 is down-regulated in the rectal epithelium of patients during shigellosis and that butyrate up-regulates the expression of LL-37 in colonic epithelial cells in vitro and decreases severity of inflammation in experimental shigellosis. In this study, Shigella-infected dysenteric rabbits were treated with butyrate (0.14 mmol/kg of body weight) twice daily for 3 days, and the expression levels of the rabbit homologue to LL-37, CAP-18, were monitored in the colon. Butyrate treatment resulted in (i) reduced clinical illness, severity of inflammation in the colon, and bacterial load in the stool, (ii) significant up-regulation of CAP-18 in the surface epithelium, and (iii) disappearance of CAP-18-positive cells in lamina propria. The active CAP-18 peptide was released in stool from its proform by butyrate treatment. In healthy controls, CAP-18 expression was localized predominantly to the epithelial surface of the colon. In infected rabbits, CAP-18 expression was localized to immune and inflammatory cells in the colon, whereas the ulcerated epithelium was devoid of CAP-18 expression. The combination of CAP-18 and butyrate was more efficient in killing Shigella in vitro than CAP-18 alone. Our findings indicate that oral butyrate treatment in shigellosis may be of clinical value because of induction of the endogenous cathelicidin CAP-18 in the colonic epithelium, stimulation of the release of the active peptide CAP-18, and promoting elimination of Shigella.

05010015020072008200920102011201220132014201520162017
Citations per Year

714 Citations

Semantic Scholar estimates that this publication has 714 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Raqib2006ImprovedOI, title={Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic.}, author={Rubhana Raqib and Protim Sarker and Peter W Bergman and Gul Ara and Monica Lindh and David A Sack and K M Nasirul Islam and Gudmundur Hrafn Gudmundsson and Jan Andersson and Birgitta Agerberth}, journal={Proceedings of the National Academy of Sciences of the United States of America}, year={2006}, volume={103 24}, pages={9178-83} }